Patients with EGFR mutations without lymph node metastases also had higher nuclear expression of P-s207 LysRS (50%) as compared to patients with lymph node metastases (27.8%) (p = 0.021). Here, EGFR is linked to metastatic malignant neoplasm in the lymph nodes.